ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |
rdf:type |
node1 |
ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |
rdf:type |
owl:Thing |
ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |
rdf:type |
prov:Person |
ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |
rdf:type |
foaf:Person |
ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |
owl:sameAs |
https://semopenalex.org/author/A5012009272 |
ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |
http://www.w3.org/ns/org#memberOf |
ripekg:organization/RIPEO81762B608E29B031Inflammatory Diseases |
ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |
foaf:familyName |
Van Vollenhoven |
ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |
foaf:givenName |
Ronald |
ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |
foaf:name |
Ronald Van Vollenhoven |
ripekg:work/10.1136%2Fannrheumdis-2014-205698Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial |
dcterms:creator |
ripekg:author/RIPEAU438FFDDE890AF659Ronald Van Vollenhoven |